Illinois has passed a law capping insulin costs at $100 per month. The law applies to people covered by state-regulated commercial health insurance plans. The bill came about after diabetes patients lobbied the state legislature about rising insulin costs. (Associated Press)
A report has suggested that two sickle cell drugs were too expensive. The report from Institute for Clinical and Economic Review said Novartis and Global Blood Therapeutics treatments were not cost effective. Both drugs cost more than $80,000. (Reuters)
President Trump has threatened to cut federal health funding to California. The threat came after California passed a requirement that private health insurers cover abortion. Five other states – Illinois, Maine, New York, Oregon and Washington – have similar laws. (Politico)
Bayer has postponed Roundup trial to continue settlement talks. The trial was scheduled to begin in Missouri on Friday. It would be the fourth Roundup-related lawsuit to go before a jury trial. (Reuters)
Roche’s Tecentriq has failed a late-stage cancer trial. The trial was studying how well Tecentriq treated a form of urothelial cancer, when used as a post-surgery treatment. Tecentriq is already approved to treat lung cancer, breast cancer and another form of urothelial cancer. (Reuters)
